Gelonghui, January 26 | CRO concept stocks weakened. Kanglong Chemical (3759.HK) in the Hong Kong stock market rose 0.8% at the beginning of the session, reaching a record high of HK$179.4. After that, Kanglong Chemical (3759.HK) fell 7.25%, Tiger Pharmaceuticals (03347.HK) fell about 5%; in the A-share market, Kanglong Chemical (002370.SZ) fell 7.2%. Kanglong Chemical announced yesterday that the net profit for the year ended December 31 last year is expected to be about 1,133 million to 1,187 million yuan, an increase of 1.07-1.17 times over the previous year, with a profit of 1.4325-1.5017 yuan per share, while net profit after deducting non-recurring profit and loss is about 778 million to 828 million yuan, an increase of 54%-64% year on year.
CRO概念股走弱 康龙化成AH齐跌逾7%
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.